Pro-Dex (co) Return on Equity

Pro-Dex (co) (PDEX) currently reports a ROE of 24.38%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Pro-Dex (co)'s ROE history and peer comparisons.

Pro-Dex (co)'s ROE of 24.38% is higher than the Healthcare sector average of -75.84%. That is roughly 132.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Pro-Dex (co)'s current 24.38% should be judged against Healthcare norms (sector average: -75.84%) and against PDEX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 24.38%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Pro-Dex (co), and consider following PDEX for alerts when major investors trade the stock.

Pro-Dex (co) is classified in the Healthcare sector. On ROE, it currently shows 24.38% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PDEX with unrelated industries.